Moreover, the levels of sulfhydrated Parkin is markedly depleted in PD brains while nitrosylation increased in tandem, suggesting that hydrogen sulfide donors may counteract S-nitrosylation-mediated inactivation of the enzyme and may accordingly be therapeutic. The gene discussed is PRKN; the disease is Parkinson disease.